Joseph Mansueto
CEO @ Advanced Sales and Marketing Corporation
Chicago, United States
Joseph Mansueto is a seed investor at Advanced Sales and Marketing Corporation in Chicago focused on Medical and Biotechnology. Joe Mansueto founded Morningstar in 1984. He has served as chairman since the company’s inception and as chief executive officer from 1984 to 1996 and again from 2000 to present.Under Mansueto’s leadership, Morningstar has been named twice to Fortune magazine’s “100 Best Companies to Work For” list, in 2011 and 2012. The Chicago Tribunerecognized Morningstar as one of the top 100 workplaces in the Chicago area in 2010, 2011, and 2012, and Crain’s Chicago Business listed Morningstar in its Fast Fifty feature in 2007, 2008, 2009, and 2011. Morningstar won the 2010 AIGA Chicago Chapter Corporate Design Leadership Award, which recognizes forward-thinking organizations that have advanced design by promoting it as a meaningful business policy.Mansueto was the recipient of the PLANSPONSOR Lifetime Achievement Award in 2013. In 2010, Mansueto received the Tiburon CEO Summit award, MutualFundWire.com named him ninth on its list of the 100 Most Influential People of the year, and Chicago magazine listed Mansueto among its top 40 Chicago pioneers over the past four decades. In 2007, SmartMoney magazine recognized Mansueto in the “SmartMoney Power 30,” its annual list of the 30 most powerful forces in business and finance. He received the Distinguished Entrepreneurial Alumnus Award from the University of Chicago Booth School of Business in 2000
- Total investments:
- 12
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Joseph Mansueto invests in
Stages Joseph Mansueto invests in
Countries Joseph Mansueto invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $800k–$4M
- Series A
- $2.4M–$9.2M
Investment Focus
Industry
- Medical 3 (25%)
- Biotechnology 2 (17%)
- News 1 (8%)
- SaaS 1 (8%)
- Local 1 (8%)
Stage
- Seed 5 (42%)
- Series A 4 (33%)
- Series B 1 (8%)
- Series C 1 (8%)
- Corporate Round 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Pippin Title
|
Pippin Title offers comprehensive title search across all 50 states. We take pride in being responsive and helpful no matter what your needs may be. Our cloud based software allows title insurance brokerages, lenders, and attorneys manage their workflows efficiently and effectively, saving them time, money, and hassle. | $3M / Seed / Jul 01, 2023 | |
Grove Biopharma
|
Grove Biopharma is a biotechnology company offering a materials science solution to peptide therapeutic challenges, focused on the discovery and development of a novel class of “protein-like polymers” to treat significant unmet medical needs in chronic inflammatory and neurodegenerative diseases. | $4M / Seed / May 10, 2021 | |
Tovala
|
Tovala combines a smart oven with a fresh meal delivery service to makes dinner effortless. Tovala is a smart oven that sits on the countertop and is paired with a companion meal delivery service. The company's meal system combines an internet-connected countertop steam oven capable of multi-step cooking with meals prepared by gourmet chefs,making dinner preparation as simple as scanning a barcode, enabling busy people to get access to an effortless way to eat delicious, healthy, home-cooked meals.The Chicago-based company was founded in 2015 and was launched in 2017. | $30M / Series C / Feb 04, 2021 | |
First Stop Health
|
First Stop Health's mission is to provide delightful healthcare experiences to our members. First Stop Health provides care that people love® with various digital healthcare services and we believe that accessing healthcare should be safe, simple and low cost without compromising quality. Every patient has their own unique healthcare journeyand with our Primary Care, Urgent Care & Mental Health, members have access to an exceptional care team for support and guidance every step of the way. Patients can access First Stop Health virtual care 24/7 via app, website or phone. First Stop Health was named one of Inc. Magazine’s Best Workplaces of 2022-2024, and ranked one of the fastest-growing private companies for the past 7 years by Inc. 5000. In 2023, First Stop Health was also recognized in Crain’s Chicago Business Fast 50 as one of the Chicago-areas' fastest growing companies and as a 2023 Well-Being Trailblazer presented by Archetype and WELCOA. | $6.5M / Series A / Jan 12, 2019 | |
Owler
|
Owler is the world’s largest community-driven business information and insights platform that provides data and real-time news updates on the companies you care about.Owler is powered by an active community of 2.7+ million business professionals, who contribute unique business insights such as competitors, private company revenue, and CEOratings. From startups to large enterprises (including 96% of the Fortune 500), CEOs, salespeople, marketers, product managers, and all types of business professionals use Owler daily.With unique data on 15 million searchable company profiles and proprietary community-driven Competitive Graph, Owler helps business professionals uncover competitive insights and discover new companies that participate in their space. Owler’s platform provides members with real-time insights not found anywhere else and helps them outsmart their competition.Owler provides a searchable database with firmographic business information, as well as a daily news update about the specific companies a user follows. Owler Pro includes real-time alerts on 15 trigger events for each followed company, as well as synchronization with a user’s prospects in their CRM.Launched in 2014, and funded by Norwest Venture Partners and Trinity Ventures, Owler is headquartered in San Mateo, CA with offices in Coimbatore, India. | $7M / Series B / Aug 27, 2018 | |
ClostraBio
|
ClostraBio develops drugs that can prevent allergic reactions to food. It is dedicated to understanding and treating food allergies and other diseases of the immune system. The company is discovering and developing new therapeutics that modulate the protective ability of the microbe.ClostraBio’s scientific team has made key discoveries thathighlight the importance of the intestinal microbiota in regulating allergic sensitization to food. The company is committed to a deeper understanding of the role of intestinal microbes in gut barrier function and determining the mechanisms of barrier protection. | $3.5M / Seed / Jan 09, 2018 | |
|
Tovala
|
Tovala combines a smart oven with a fresh meal delivery service to makes dinner effortless. Tovala is a smart oven that sits on the countertop and is paired with a companion meal delivery service. The company's meal system combines an internet-connected countertop steam oven capable of multi-step cooking with meals prepared by gourmet chefs,making dinner preparation as simple as scanning a barcode, enabling busy people to get access to an effortless way to eat delicious, healthy, home-cooked meals.The Chicago-based company was founded in 2015 and was launched in 2017. | Corporate Round / Jan 01, 2018 | |
|
Tovala
|
Tovala combines a smart oven with a fresh meal delivery service to makes dinner effortless. Tovala is a smart oven that sits on the countertop and is paired with a companion meal delivery service. The company's meal system combines an internet-connected countertop steam oven capable of multi-step cooking with meals prepared by gourmet chefs,making dinner preparation as simple as scanning a barcode, enabling busy people to get access to an effortless way to eat delicious, healthy, home-cooked meals.The Chicago-based company was founded in 2015 and was launched in 2017. | $9.2M / Series A / Dec 18, 2017 | |
Built In
|
Built In is a network of online communities operating as a recruitment solution for tech companies and startups in seven major tech markets. Their mission is to help talented people find their professional purpose; companies tell their stories (in a way no job post ever could), and communities connect over a shared passion for tech.The companycurrently operates seven sites in Chicago, Los Angeles, Colorado, Austin, NYC, Boston, and Seattle, and is headquartered in Chicago. It was founded in 2010. | $2.4M / Series A / Nov 14, 2016 | |
|
Built In
|
Built In is a network of online communities operating as a recruitment solution for tech companies and startups in seven major tech markets. Their mission is to help talented people find their professional purpose; companies tell their stories (in a way no job post ever could), and communities connect over a shared passion for tech.The companycurrently operates seven sites in Chicago, Los Angeles, Colorado, Austin, NYC, Boston, and Seattle, and is headquartered in Chicago. It was founded in 2010. | $1.1M / Seed / Oct 01, 2015 | |
| See all 12 investments → | |||
Co-Investors
About Advanced Sales and Marketing Corporation
Advanced Sales & Marketing Corporation provides annuity intelligence and research services for the financial services industry. It offers The Annuity Intelligence Report, a Web-based tool that provides information on variable annuity products for broker/dealers, insurers, advisory firms, insurance companies, and financial professionals;and MaxPlan wholesaler productivity system, a business planning and territory management tool for mutual fund and annuity distributors. The company was incorporated in 2001 and is based in Oakbrook Terrace, Illinois.
Advanced Sales and Marketing Corporation Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Joseph Mansueto
CEO
|
|||
Scott Cooley
CFO
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Joseph Mansueto invest in?
Joseph Mansueto invests primarily in Medical, Biotechnology and News startups, most often at Seed and Series A stage. Most of the 12 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Joseph Mansueto's check size?
Joseph Mansueto typically joins rounds of $800k–$4M at Seed and $2.4M–$9.2M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Joseph Mansueto participates in.
How do I contact Joseph Mansueto?
Public channels for Joseph Mansueto include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Joseph Mansueto last invest?
The most recent investment recorded for Joseph Mansueto closed in Jul 2023. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
